Streptokinase suppository - Heber Biotec

Drug Profile

Streptokinase suppository - Heber Biotec

Alternative Names: Proctokinase; rSK suppository - Heber Biotec

Latest Information Update: 05 Feb 2016

Price : $50

At a glance

  • Originator Center for Genetic Engineering and Biotechnology
  • Developer Center for Genetic Engineering and Biotechnology; Heber Biotec
  • Class Coenzymes; Plasminogen activator enzymes; Thrombolytics
  • Mechanism of Action Plasmin stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Marketed Haemorrhoids

Most Recent Events

  • 31 Jul 2013 The Center for Genetic Engineering and Biotechnology and Heber Biotec complete the phase II THERESA-2 trial in Haemorrhoids in Cuba
  • 20 Dec 2010 Phase-II clinical trials in Haemorrhoids in Cuba (Rectal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top